Home » Topics » BioWorld Science

BioWorld Science
RSS

OliX expands ocular disease pipeline with new OLX-304A program in retinitis pigmentosa

May 13, 2019

EnGeneIC initiates phase I/IIa study of EDV-based therapeutic in advanced pancreatic cancer

May 13, 2019

Impaired placental function linked to neurodevelopmental disorders

May 13, 2019

Urinary NT-proBNP a pulmonary hypertension marker in preterm infants with bronchopulmonary dysplasia

May 10, 2019

Liver chats with fat via serum protein GPNMB

May 10, 2019

Pooled safety analyses of global roxadustat phase III program confirm CV safety

May 10, 2019

BioCryst completes phase I study of intravenous galidesivir in healthy subjects

May 10, 2019

Mustang announces new phase I trial of CAR T-cell therapy for multiple myeloma

May 10, 2019

Aptose begins phase Ia/Ib study of CG-806 in CLL, SLL and NHL

May 10, 2019

New phase I trial explores Precigen's PRGN-3005 UltraCAR-T cells for advanced ovarian cancer

May 10, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...